Mesirow Financial Investment Management’s Adaptive Biotechnologies ADPT Stock Holding History

Mesirow Financial Investment Management’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18,715	Closed	-$280K	–	488
2025 Q3	$280K	Hold	18,715	–	–	0.01%	469
2025 Q2	$218K	Hold	18,715	–	–	﹤0.01%	492
2025 Q1	$139K	Hold	18,715	–	–	﹤0.01%	553
2024 Q4	$112K	Hold	18,715	–	–	﹤0.01%	572
2024 Q3	$95.8K	Hold	18,715	–	–	﹤0.01%	571
2024 Q2	$67.7K	Hold	18,715	–	–	﹤0.01%	492
2024 Q1	$60.1K	Hold	18,715	–	–	﹤0.01%	506
2023 Q4	$91.7K	Buy	+18,715	New	+$85.4K	﹤0.01%	539

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mesirow Financial Investment Management's ADPT Position: Q4 2025 in Review

Mesirow Financial Investment Management sold out of Adaptive Biotechnologies (ADPT) in Q4 2025, closing a stake of 18,715 shares — an estimated $280K sold.

Mesirow Financial Investment Management first reported a position in ADPT in Q4 2023 and held it in 8 quarters. The position peaked at $280K in Q3 2025. 283 funds tracked by Wall St. Rank hold ADPT as of Q4 2025.

Mesirow Financial Investment Management reported no remaining Adaptive Biotechnologies position as of Q4 2025 after selling out during the quarter.
Mesirow Financial Investment Management sold 18,715 Adaptive Biotechnologies shares in Q4 2025, an estimated $280K.
Mesirow Financial Investment Management first reported a position in Adaptive Biotechnologies in Q4 2023 and held it in 8 quarters.
Mesirow Financial Investment Management's Adaptive Biotechnologies position peaked at $280K in Q3 2025.
283 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2025.

Based on Mesirow Financial Investment Management's 13F filing for Q4 2025, filed 5 Feb 2026.